News & Updates
Filter by Specialty:

Superior IBD control achieved with biomarker-guided therapy standard care
26 May 2025
byJairia Dela Cruz
Biomarker-informed molecular guidance improves anti-TNF therapy outcomes in patients with inflammatory bowel disease (IBD), increasing the likelihood of achieving disease control when compared with standard “best care,” as shown in the GUIDE-IBD trial.